Alexithymie et appauvrissement onirique chez des populations cliniques souffrant de troubles du sommeil

Le premier objectif de cette étude était d’évaluer la relation entre l’alexithymie et différents troubles du sommeil chez des patients diagnostiqués (N= 580) selon la polysomnographie et la classification de l’American Academy of Sleep Medicine (AASM) et chez des sujets contrôle (N= 145) en utilisant l’Échelle d’Alexithymie de Toronto à 20 items (TAS-20). Le deuxième objectif était d’estimer le lien entre l’alexithymie et des caractéristiques de rêves suivant un Questionnaire sur les Rêves de 14 items. Les résultats confirment un lien entre l’alexithymie et les troubles du sommeil. Sa prévalence était supérieure dans le groupe clinique comparativement au groupe contrôle, et était différente selon les troubles. Les hommes cotaient plus haut que les femmes à l’Échelle d’Alexithymie de Toronto à 20 items (TAS-20) et sur ses sous-échelles DDF (difficulty describing feeling) et EOT (externally oriented thinking). L’EOT pourrait être impliquée dans les troubles de sommeil en étant l’unique sous-échelle, où un effet principal des diagnostics était significatif dans le groupe clinique. Pour les rêves, le score du TAS-20 corrélait positivement avec le facteur « détresse des cauchemars »; et négativement avec « rappel de rêves » et « signification des rêves ». Les sous-échelles du TAS-20 avaient des corrélations différentes: positive entre DIF et « détresse des cauchemars », négative entre DDF et « rappel de rêves » et EOT avec « signification des rêves ». À part quelques exceptions, ces modèles sont obtenus pour les groupes cliniques et non-cliniques, et pour les hommes et les femmes dans ces deux groupes. Ces résultats suggèrent un modèle consistant, et reproductible, de relations entre l’alexithymie et les composantes des rêves.Using a large clinical group of patients suffering from sleep disorders (N= 580) and non-clinical comparison subjects (N= 145), the first aim of this study was to evaluate the relationship between alexithymia and several different sleep disorders diagnosed from polysomnography following the American Academy of Sleep Medicine classification system and using a Canadian French translation of the 20-item Toronto Alexithymia scale (TAS-20). The second objective was to evaluate the link between alexithymia and dream characteristics using a 14-item Dreaming Questionnaire. Results confirm a relationship between alexithymia and sleep disorders. Its prevalence was higher in the clinical than the non-clinical group and differed according to sleep disorder diagnoses. Men scored higher than women on the TAS-20 total score and on the DDF (difficulty describing feeling) and EOT (externally oriented thinking) subscales. EOT could be implicated in sleep disorders pathology as it was the only subscale for which the sleep diagnosis effect was significant in the clinical group. Concerning the second objective, TAS-20 total score correlated positively with nightmare distress and negatively with dream recall; and correlated negatively with dream meaning. TAS-20 subscales were differentially correlated with the 3 dream factors of the Dreaming Questionnaire: DIF with increased nightmare distress, DDF with decreased dream recall and EOT with decreased dream meaning. With some exceptions, these patterns were obtained for clinical and non-clinical groups and for men and women. These results suggest a consistent and replicable pattern of relationships between alexithymia and dreaming components

Imagery Rehearsal Therapy (IRT) Combined with Cognitive Behavioral Therapy (CBT)

In cases of post-traumatic stress disorder (PTSD), nightmares can often persist, even after a cognitive behavioral therapy (CBT) for this disorder. Imagery rehearsal therapy (IRT) is a CBT that targets the treatment of nightmares directly. Objectives: the present study describes the feasibility and the efficacy of combining IRT with first-line, trauma-focused CBT for PTSD. Method: two individuals with PTSD took part in this experimental case study protocol. The efficacy of the combined treatment was evaluated using semi-structured interviews, self-report questionnaires, and daily self-monitoring diaries. Results: after three IRT sessions for Participant 1 and five IRT sessions for Participant 2, combined with CBT for PTSD, both participants experienced a slight decrease in sleep difficulties and in the intensity of their PTSD symptoms post-treatment. More particularly, one participant demonstrated a significant decrease in the level of distress associated with his post-traumatic nightmares (PTNM). Conclusions: these results demonstrate that it is possible and promising to combine IRT with CBT for PTSD

Nightmare frequency, nightmare distress and the efficiency of trauma-focused cognitive behavioral therapy for post-traumatic stress disorder

Background: Up to 71% of trauma victims diagnosed with PTSD have frequent nightmares (NM), compared to only 2% to 5% of the general population. Objectives: The present study examined whether nightmares before the beginning of cognitive behavior therapy (CBT) for posttraumatic stress disorder (PTSD) could influence overall PTSD symptom reduction for 71 individuals with PTSD and different types of traumatic events. Patients and Methods: Participants received a validated CBT of 20 weekly individual sessions. They were evaluated at five measurement times: at pre-treatment, after the third and ninth session, at post-treatment, and at 6 months follow-up. Results: The presence of nightmares did not impact overall CBT efficiency. Specific CBT components were efficient in reducing the frequency and distress of nightmares. Conclusions: Most participants no longer had PTSD but some still had nightmares

The Impact of Cognitive-Behavioral Therapies for Nightmares and Prazosin on the Reduction of Post-Traumatic Nightmares, Sleep, and PTSD Symptoms: A Systematic Review and Meta- Analysis of Randomized and Non‐Randomized Studies

Post-traumatic nightmares (PTNMs) can be treatment resistant to conventional treatments for post-traumatic stress disorder (PTSD). New cognitive and behavioral treatments (CBTs) for nightmares (NM) and pharmacological treatments, such as Prazosin, have been developed to directly reduce PTNMs. Objectives: The first objective was to evaluate the impact of CBTs for NM and Prazosin on the reduction of PTNMs in an adult population. A second aim was to explore the impact of these treatments in general PTSD symptoms and sleep. Method: A systematic search of English and French clinical studies on any CBTs and Prazosin treatments for PTNMs published from 1980 to 2012 was conducted in PsycINFO, MedLine, PILOTS,and ProQuest Dissertations and Theses. Results: The final sample was composed of 26 studies. The combined effect size (ES) for Prazosin was g = 1.30, 95% CI [0.61, 2.00], and for CBTs, it was g = 0.55, 95% CI [0.38, 0.72]. Conclusions: Prazosin had a large impact on PTNM reduction, while CBTs had a moderate impact. Specific NM treatments (Prazosin or CBTs) contribute to PTNM reduction and reduce PTSD and sleep symptoms. These findings are significant to the literature on PTSD and future studies should consider them. Several recommendations are proposed